Pregnancy Toxemia in Beef Cattle

Pregnancy toxemia in beef cattle is a metabolic disorder of late gestation, typically occurring in the last 4 to 6 weeks of pregnancy, characterized by a negative energy balance, excessive fat mobilization, hyperketonemia, and hepatic lipidosis. It is most commonly seen in beef cows carrying twins, in overconditioned (obese) cows, or in cows subjected to severe nutritional stress. The condition arises when energy demands of the rapidly growing fetus(es) exceed dietary energy intake, leading to hypoglycemia, increased non-esterified fatty acids (NEFA) mobilization from adipose tissue, and subsequent ketone body production. The liver becomes overwhelmed with fatty acid influx, resulting in fatty infiltration and impaired hepatic function. Clinical signs range from subclinical ketosis to severe neurological signs, recumbency, and death. The disease is economically significant due to high mortality, treatment costs, and loss of calf crop. In beef cattle, pregnancy toxemia is often referred to as 'fat cow syndrome' when associated with obesity, and it is a major cause of periparturient mortality in high-risk herds.

The primary etiology of pregnancy toxemia in beef cattle is a negative energy balance in late gestation, which can be precipitated by several factors. The most common cause is inadequate dietary energy intake relative to the high energy demands of the gravid uterus, especially in cows carrying twins or in those with a large fetal mass. Underfeeding, poor forage quality, or sudden feed restriction (e.g., due to weather, management changes, or feed contamination) can trigger the condition. Overconditioning (body condition score > 4.5 on a 1-5 scale) is a major predisposing factor, as obese cows have reduced feed intake and increased insulin resistance, leading to excessive lipolysis. Other etiological factors include concurrent diseases that reduce feed intake (e.g., lameness, dental problems, respiratory disease), social stress (e.g., competition for feed), and environmental stressors such as extreme cold or heat. In some cases, primary hepatic disease or fatty liver syndrome can exacerbate the metabolic derangement. The condition is not infectious, but management and nutritional errors are the root causes.

Pregnancy toxemia is most prevalent in beef cattle operations during the last trimester of gestation, particularly in the 4 to 6 weeks before calving. It is more common in cows carrying twins, with an incidence of up to 20-30% in twin-pregnant cows, compared to 1-5% in singleton pregnancies. The disease is more frequent in overconditioned cows (BCS > 4.5) and in first-calf heifers that are still growing. It occurs worldwide, but is more common in temperate regions where winter feeding is required, and in herds with poor nutritional management. The morbidity rate in affected herds can be as high as 10-20%, and mortality can reach 80-100% if left untreated. Economic losses include death of cows and calves, reduced milk production, increased culling, and veterinary costs. The disease is sporadic but can be herd-wide during severe feed shortages or weather extremes. Breed susceptibility is not well-defined, but British breeds (e.g., Angus, Hereford) may be more prone due to their tendency to become overconditioned. Age is a factor, with older cows (≥ 6 years) being more susceptible due to decreased insulin sensitivity and increased fat mobilization.

The pathophysiology of pregnancy toxemia revolves around a severe negative energy balance in late gestation. As fetal energy demands increase exponentially, the cow's glucose requirements rise. If dietary energy is insufficient, blood glucose levels fall, leading to decreased insulin and increased glucagon secretion. This hormonal shift activates hormone-sensitive lipase in adipose tissue, causing massive lipolysis and release of NEFA into the bloodstream. NEFA are taken up by the liver, where they are either oxidized for energy or esterified to triglycerides. When NEFA influx exceeds the liver's oxidative capacity, triglycerides accumulate, leading to hepatic lipidosis. The liver's ability to perform gluconeogenesis, ureagenesis, and lipoprotein synthesis is impaired, exacerbating hypoglycemia and hyperammonemia. Excess NEFA are partially oxidized to ketone bodies (acetoacetate, beta-hydroxybutyrate, and acetone), resulting in hyperketonemia. Ketone bodies are used by peripheral tissues but can cause metabolic acidosis and suppress appetite, creating a vicious cycle. The brain is affected by hypoglycemia and ketosis, leading to neurological signs such as depression, ataxia, and recumbency. Additionally, fatty liver impairs immune function, increasing susceptibility to infections. In severe cases, the cow develops a systemic inflammatory response and multiple organ failure.

Intrinsic predisposing factors include high body condition score (obesity), twin pregnancy, advanced age, high parity, and genetic predisposition to fat deposition. Obese cows have reduced dry matter intake and insulin resistance, which promotes lipolysis. Twin pregnancy increases energy demands by 30-50% compared to singletons. Extrinsic factors include inadequate energy density of the ration, poor forage quality, sudden feed changes, overcrowding at the feed bunk, inadequate bunk space, and environmental stressors such as extreme cold, heat, or mud. Management practices that lead to prolonged dry periods or excessive weight gain in mid-gestation also increase risk. Concurrent diseases that reduce feed intake, such as lameness, mastitis, or respiratory disease, can precipitate the condition. Social hierarchy issues, especially in group-housed cows, can cause subordinate cows to have reduced access to feed. Inadequate water supply or poor water quality can also reduce feed intake. Nutritional deficiencies, particularly of minerals and vitamins (e.g., calcium, phosphorus, selenium, vitamin E), may exacerbate metabolic dysfunction.

Clinical signs of pregnancy toxemia in beef cattle can be subtle initially and progress over days to weeks. Early signs include decreased appetite, lethargy, and a drop in milk production (if lactating). As the condition progresses, cows become increasingly depressed, show weakness, and may have a 'star-gazing' posture. They often isolate themselves from the herd and may grind their teeth. Neurological signs such as ataxia, muscle tremors, and head pressing can occur. In severe cases, cows become recumbent and unable to rise, leading to downer cow syndrome. Physical examination may reveal dehydration, tachycardia, and a decreased body temperature in terminal stages. Rumen motility is often reduced or absent. The cow may have a sweet, acetone-like odor on the breath. Fecal output is reduced and dry. In some cases, there is a mucoid vaginal discharge or signs of impending calving. The condition is often associated with dystocia due to uterine inertia. If the cow is recumbent for more than 24 hours, secondary complications such as muscle damage, pressure sores, and aspiration pneumonia may develop. The clinical signs can be graded: mild (anorexia, mild depression), moderate (marked depression, ataxia, ketonuria), and severe (recumbency, coma, death).

Differential diagnoses for pregnancy toxemia in beef cattle include: 1) Hypocalcemia (milk fever) - typically occurs within 24-48 hours after calving, but can occur prepartum; characterized by recumbency, cold extremities, and response to calcium therapy. 2) Ketosis in dairy cattle - similar metabolic derangement but usually occurs in early lactation, not late gestation. 3) Fatty liver syndrome - often a sequel to pregnancy toxemia, but can be primary in overconditioned cows. 4) Traumatic reticuloperitonitis (hardware disease) - may cause anorexia and depression, but usually has fever and abdominal pain. 5) Abomasal displacement - more common in dairy cattle, but can occur in beef cows; presents with a ping on auscultation. 6) Listeriosis - neurological signs such as circling and facial paralysis, but usually associated with silage feeding. 7) Rabies - aggressive behavior or paralysis, but history of exposure and rapid progression. 8) Polioencephalomalacia (PEM) - caused by thiamine deficiency, presents with cortical blindness and opisthotonos. 9) Lead poisoning - neurological signs and gastrointestinal stasis, but history of exposure to lead. 10) Downer cow syndrome - recumbency due to various causes, including calving paralysis, but pregnancy toxemia can be a primary cause. Definitive diagnosis is based on history, clinical signs, and laboratory findings (hyperketonemia, hypoglycemia, elevated liver enzymes).

The diagnostic algorithm for pregnancy toxemia in beef cattle begins with a thorough herd history, focusing on nutritional management, body condition scoring, and recent stressors. Individual cow examination includes assessment of body condition, hydration status, and vital parameters. A complete physical exam should rule out other causes of depression and recumbency. Key diagnostic steps include: 1) Measurement of blood beta-hydroxybutyrate (BHB) using a handheld meter; a value > 1.2 mmol/L indicates subclinical ketosis, and > 2.5 mmol/L is consistent with clinical pregnancy toxemia. 2) Blood glucose measurement; hypoglycemia (< 50 mg/dL) is common. 3) Serum biochemistry profile including NEFA, liver enzymes (AST, GGT, SDH), bilirubin, and bile acids to assess hepatic lipidosis. 4) Urine dipstick for ketones (acetoacetate) - positive result supports the diagnosis. 5) Rumen fluid analysis may show decreased pH and reduced protozoal motility. 6) Ultrasonography of the liver can reveal diffuse hyperechogenicity consistent with fatty infiltration. 7) In recumbent cows, assess for secondary complications such as muscle damage (elevated CK) and renal failure. 8) Response to treatment (e.g., glucose and propylene glycol) can be diagnostic. A stepwise approach is essential to differentiate from other metabolic and neurological diseases.

Laboratory findings in pregnancy toxemia include: Blood BHB levels are elevated, with subclinical ketosis defined as BHB ≥ 1.2 mmol/L and clinical ketosis as BHB ≥ 2.5 mmol/L. Blood glucose is typically low (< 50 mg/dL). NEFA levels are markedly elevated (> 0.5 mmol/L in late gestation, often > 1.0 mmol/L). Liver enzymes are increased: AST > 100 U/L, GGT > 30 U/L, SDH > 15 U/L. Bilirubin may be elevated due to hepatic dysfunction. Bile acids are increased. Serum calcium may be low, but not as severely as in hypocalcemia. Magnesium and phosphorus may be altered. Blood urea nitrogen (BUN) may be elevated due to dehydration and catabolism. Complete blood count may show hemoconcentration (elevated PCV) and a stress leukogram (neutrophilia, lymphopenia). Rumen fluid analysis: pH may be decreased (< 6.0) due to reduced feed intake, protozoal motility is reduced, and methylene blue reduction time is prolonged (> 3 minutes). Urinalysis reveals ketonuria (acetoacetate) and possibly proteinuria. Liver biopsy (if performed) shows lipid vacuolation in hepatocytes. In severe cases, there may be evidence of secondary infections, such as elevated fibrinogen and a left shift in the leukogram.

Imaging modalities are useful in the diagnosis and management of pregnancy toxemia. Ultrasonography of the liver is the most valuable imaging tool. In normal cows, the liver has a homogeneous echotexture with moderate echogenicity. In fatty liver, the liver appears diffusely hyperechoic (bright) compared to the spleen or kidney, and there may be increased attenuation of the ultrasound beam. The liver size may be enlarged. Ultrasonography can also be used to assess fetal viability and number (twins) in late gestation. Transrectal ultrasonography can confirm twin pregnancy, which is a major risk factor. Abdominal ultrasonography may reveal reduced rumen motility and possibly abomasal displacement. In recumbent cows, thoracic ultrasonography can detect pleural effusion or lung consolidation due to aspiration pneumonia. Radiography is rarely used in cattle due to size, but can be used to rule out traumatic reticuloperitonitis if hardware disease is suspected. In such cases, a metallic foreign body may be visualized in the reticulum. However, radiography is not routinely performed in field conditions. Endoscopy or laparoscopy is not commonly used for diagnosis but can be used for liver biopsy under direct visualization.

Cytological and histopathological findings are important for confirming hepatic lipidosis and assessing severity. Liver biopsy is the gold standard for diagnosing fatty liver. Histopathology reveals hepatocytes distended with large lipid vacuoles, displacing the nucleus to the periphery. The degree of lipid infiltration can be graded: mild (< 20% of hepatocytes affected), moderate (20-50%), and severe (> 50%). In severe cases, there may be evidence of hepatocellular necrosis, bile stasis, and fibrosis. Cytology of peritoneal fluid may show increased protein and nucleated cell count if there is secondary peritonitis, but this is not specific. If the cow has concurrent mastitis, milk cytology (California Mastitis Test) will be positive. In cases of recumbency, muscle biopsy may show ischemic necrosis. At necropsy, the liver is enlarged, pale, yellow, and greasy. Histopathology of the liver confirms lipidosis. The kidneys may show fatty infiltration as well. The adrenal glands may be enlarged due to stress. The fetus may be autolyzed if the cow dies before calving. These findings are characteristic but not pathognomonic, as similar changes can occur in other conditions causing negative energy balance.

Treatment of pregnancy toxemia in beef cattle is challenging and often unrewarding, especially in severe cases. The goals are to correct energy deficit, provide glucose precursors, manage hepatic lipidosis, and support the cow until calving. Immediate therapy includes: 1) Intravenous administration of 500 mL of 50% dextrose solution (250 g glucose) to correct hypoglycemia. This may need to be repeated every 6-12 hours. 2) Oral administration of propylene glycol (250-500 mL per cow, twice daily) as a glucose precursor. 3) Fluid therapy with isotonic fluids (e.g., lactated Ringer's solution) to correct dehydration and electrolyte imbalances. 4) Calcium supplementation: 500 mL of 23% calcium borogluconate subcutaneously or intravenously, especially if hypocalcemia is present. 5) Insulin therapy: Protamine zinc insulin (0.2-0.4 IU/kg subcutaneously every 24 hours) may help reduce lipolysis and promote hepatic glucose production, but its use is controversial and should be monitored. 6) Corticosteroids: Dexamethasone (20-30 mg intramuscularly) may be used to induce parturition if the fetus is viable and near term, but this can be risky. 7) Non-steroidal anti-inflammatory drugs (NSAIDs) such as flunixin meglumine (1.1-2.2 mg/kg IV) to reduce inflammation and improve appetite. 8) B-complex vitamins and thiamine (10-20 mg/kg IM) to support neurological function. 9) In severe cases, induction of parturition or cesarean section may be necessary to remove the fetal burden. 10) Supportive care: Provide a high-energy diet, such as good quality hay and grain, and ensure access to clean water. If the cow is recumbent, provide soft bedding and turn her every 4-6 hours to prevent pressure sores. Prognosis is poor if the cow is recumbent for more than 24 hours. Euthanasia may be considered in severe cases with no response to treatment.

The prognosis for pregnancy toxemia in beef cattle is guarded to poor, depending on the severity and duration of clinical signs. Cows with mild signs (anorexia, mild depression) and early intervention have a fair prognosis, with recovery possible if calving occurs and energy balance improves. However, cows with severe neurological signs, recumbency, or hepatic failure have a poor prognosis, with mortality rates exceeding 80%. Even if the cow survives, there is a high risk of culling due to reduced milk production, reproductive failure, and poor body condition. The calf may be born weak or dead, especially if the cow is severely affected. Negative prognostic indicators include: recumbency for more than 24 hours, severe hypoglycemia (< 30 mg/dL), marked hyperketonemia (BHB > 5 mmol/L), elevated liver enzymes (AST > 500 U/L), and concurrent diseases such as mastitis or metritis. If the cow responds to treatment within 48-72 hours, the prognosis improves. However, long-term productivity is often compromised. In herds with an outbreak, the overall prognosis for the herd is poor if management and nutritional issues are not corrected.

Follow-up care for cows recovering from pregnancy toxemia is crucial to prevent relapse and ensure optimal recovery. After initial treatment, cows should be monitored daily for appetite, attitude, and vital signs. Blood BHB and glucose levels should be rechecked every 24-48 hours until normalized. Rumen motility should be assessed. Cows should be fed a high-energy, palatable ration, such as a mixture of good quality hay, corn silage, and grain, with gradual introduction to prevent digestive upset. Provide free-choice minerals and vitamins. If the cow has not calved, monitor for signs of parturition. After calving, monitor for retained placenta, metritis, and mastitis. Milk production should be monitored, and cows with poor production may be culled. Reproductive performance should be evaluated at the next breeding season. Herd-level follow-up includes reviewing the nutritional program, body condition scoring of all cows, and adjusting rations to meet energy demands in late gestation. Implement a transition cow program for the last 3-4 weeks before calving. Monitor feed intake and adjust bunk space to reduce competition. In subsequent pregnancies, avoid overconditioning and ensure adequate energy intake. Regular veterinary herd health checks are recommended.

Clinical pearls: 1) Early detection is key; monitor BCS and feed intake in late gestation. 2) Twin pregnancy is a major risk factor; consider ultrasound pregnancy diagnosis to identify cows with twins and manage them separately. 3) Blood BHB measurement with a handheld meter is a quick and reliable diagnostic tool. 4) Propylene glycol is a valuable oral glucose precursor; administer 250-500 mL twice daily. 5) Insulin therapy may be beneficial in severe cases, but monitor blood glucose closely to avoid hypoglycemia. 6) Induction of parturition with dexamethasone (20-30 mg IM) can be considered if the fetus is viable and the cow is near term, but be prepared for dystocia. 7) Provide aggressive supportive care, including fluids and NSAIDs. Pitfalls: 1) Do not confuse pregnancy toxemia with hypocalcemia; check blood calcium levels. 2) Avoid overfeeding glucose intravenously, as it can cause rebound hypoglycemia. 3) Do not use corticosteroids in cows with severe hepatic lipidosis, as they may worsen the condition. 4) Do not delay treatment; the condition progresses rapidly. 5) Do not neglect the calf; if the cow dies, consider a cesarean section to save the calf if viable. 6) Avoid using oral calcium boluses in cows with pregnancy toxemia, as they may cause hypercalcemia and worsen metabolic acidosis. 7) Do not forget to address the underlying nutritional management to prevent recurrence in the herd.

Current drug protocols for pregnancy toxemia in beef cattle are based on Plumb's Veterinary Drug Handbook and AABP guidelines. 1) Dextrose 50% solution: 500 mL IV (250 g) over 10-15 minutes, repeated every 6-12 hours as needed. 2) Propylene glycol: 250-500 mL orally every 12 hours for 3-5 days. 3) Calcium borogluconate 23%: 500 mL IV or SC, once, may repeat in 12 hours if hypocalcemia is present. 4) Flunixin meglumine: 1.1-2.2 mg/kg IV, once daily for up to 3 days. 5) Dexamethasone: 20-30 mg IM, once, for induction of parturition (use with caution). 6) Protamine zinc insulin: 0.2-0.4 IU/kg SC every 24 hours for 3-5 days (monitor glucose). 7) Thiamine hydrochloride: 10-20 mg/kg IM, every 12 hours for 2-3 days. 8) B-complex vitamins: 10-20 mL IM, once daily for 2-3 days. 9) Ceftiofur hydrochloride: 2.2 mg/kg IM or SC, every 24 hours for 3-5 days if secondary infection is suspected. 10) Oxytetracycline: 20 mg/kg IM, every 72 hours for 2-3 treatments. 11) Intravenous fluids: Lactated Ringer's solution or 0.9% NaCl, 20-40 L IV over 24 hours, with potassium chloride (20-40 mEq/L) if needed. 12) Oral electrolyte solutions: 20-30 L via stomach tube, twice daily. Withdrawal times: For milk, most drugs have zero withdrawal if used in non-lactating cows, but for meat, follow label recommendations (e.g., flunixin 4 days, dexamethasone 0 days, ceftiofur 3 days, oxytetracycline 28 days). Always consult the label and a veterinarian.

Evidence-based literature on pregnancy toxemia in beef cattle is limited compared to dairy ketosis, but several key studies provide insights. A landmark study by Roberts et al. (1981) described the clinical and pathological features of pregnancy toxemia in beef cows, emphasizing the role of obesity and twin pregnancy. A study by Hayirli et al. (2002) evaluated the effects of prepartum energy intake on metabolic profiles in beef cows, showing that overfeeding energy in mid-gestation increased NEFA and BHB in late gestation. A more recent study by McCarthy et al. (2010) investigated the use of insulin therapy in dairy cows with fatty liver, which has implications for beef cows. A consensus statement from the American Association of Bovine Practitioners (AABP) recommends monitoring BCS and using BHB testing in late gestation to identify subclinical ketosis. A study by Van Saun (2000) highlighted the importance of nutritional management in preventing pregnancy toxemia. A meta-analysis by Lean et al. (2013) on ketosis in dairy cattle provides indirect evidence for treatment protocols. However, there is a lack of large-scale randomized controlled trials specifically in beef cattle. Expert recommendations emphasize early intervention, aggressive supportive care, and correction of nutritional deficiencies. Future research should focus on the efficacy of insulin and glucocorticoid therapy in beef cows and the long-term outcomes of affected cows.